RVMD
Revolution Medicines, Inc.
+1.08 (+0.55%)197.00USD840K成交股數42.2B市值–本益比(近四季)–股價營收比–營收年增(近四季)2026-11-04下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | 0.00 | 0.00-100% | 0.00-100% | 0.00 | 0.00 | 3.8M | 7.0M |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 395M | 344M | 263M | 224M | 206M | 188M | 152M | 135M | 118M | 108M | 98.0M | 68.9M |
| 銷售管理費用 | 110M | 101M | 52.8M | 40.6M | 35.0M | 28.8M | 24.0M | 21.7M | 22.8M | 15.5M | 14.6M | 13.2M |
| 營業利益 | −505M+110% | −445M+106% | −315M+79% | −265M+69% | −241M+71% | −216M+76% | −176M+62% | −157M+108% | −141M | −123M | −109M | −75.2M |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | -2,845.1% | -1,071.5% |
| 稅後淨利 | −644M+202% | −454M+133% | −305M+95% | −248M+86% | −213M+84% | −194M+79% | −156M+59% | −133M+96% | −116M | −108M | −98.3M | −68.1M |
| 淨利率 | – | – | – | – | – | – | – | – | – | – | -2,570.6% | -970.9% |
| 稀釋 EPS | -3.06+171% | -2.29+103% | -1.61+71% | -1.31+62% | -1.13+61% | -1.13+14% | -0.94+2% | -0.81+13% | -0.70 | -0.99 | -0.92 | -0.72 |
| 稀釋股數 | 211M | 198M | 189M | 189M | 188M | 168M | 167M | 165M | 165M | 109M | 107M | 94.8M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 815M | 441M | 217M | 402M | 334M | 543M | 201M | 276M | 288M | 358M | 380M | 427M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 4.3B | 2.3B | 2.3B | 2.4B | 2.4B | 2.6B | 1.8B | 1.8B | 1.9B | 984M | 1.1B | 1.1B |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 1.7B | 754M | 655M | 564M | 287M | 293M | 197M | 190M | 183M | 147M | 143M | 121M |
| 股東權益 | 2.6B | 1.5B | 1.6B | 1.9B | 2.1B | 2.3B | 1.6B | 1.6B | 1.7B | 837M | 931M | 952M |
| 負債比 | 39.7% | 33.4% | 29.1% | 23.2% | 12.1% | 11.5% | 11.2% | 10.5% | 9.6% | 14.9% | 13.3% | 11.3% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −354M | – | – | −194M+21% | – | – | – | −161M | – | – | −62.4M |
| 資本支出 | – | 1.5M | – | – | 3.3M | – | – | – | 3.2M | – | – | 1.8M |
| 自由現金流 | – | −356M | – | – | −198M+21% | – | – | – | −164M | – | – | −64.1M |
| 折舊攤銷 | – | 2.3M | – | – | 1.7M | – | – | – | 1.5M | – | – | 1.2M |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | -914.6% |
營收拆解 2022 年度 10-K 的分部揭露 · 年增對前一年度
產品／服務2022 年度 · 35.4M
| Collaboration Revenue | 35.4M | 100.0% | +20.4% |
|---|
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 0.00 | – | −1.1B | –% | -5.95 | −914M |
| FY2024 | 0.00 | -100.0% | −600M | –% | -3.58 | −568M |
| FY2023 | 11.6M | -67.3% | −436M | -3,765.1% | -3.86 | −358M |
| FY2022 | 35.4M | +20.4% | −249M | -703.8% | -3.08 | −235M |
| FY2021 | 29.4M | -31.6% | −187M | -636.3% | -2.57 | −154M |
| FY2020 | 43.0M | -14.1% | −108M | -251.6% | -2.01 | −103M |
| FY2019 | 50.0M | +148.2% | −47.7M | -95.2% | -22.33 | −52.2M |
| FY2018 | 20.2M | – | −41.8M | -207.2% | -21.24 | −286K |